Literature DB >> 5537846

[The distribution and elimination of intralumbarly administered homologous tetanus antitoxin. Immunological and physico-chemical studies of the cerebrospinal fluid and serum of tetanus patients after lumbar administration of human tetanus hyperimmune globulin].

W Auerswald, B Binder, W Doleschel, J Krenn, J Mlczoch, H Müller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 5537846     DOI： 10.1007/bf01485525

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  10 in total

Review 1.  [CURRENT TETANUS PROBLEMS].

Authors:  M WOLF
Journal:  Dtsch Gesundheitsw       Date:  1964-07-30

2.  [TETANUS AND ITS TREATMENT].

Authors:  M SCHNEIDER
Journal:  Dtsch Gesundheitsw       Date:  1964-08-13

3.  Role of serum therapy in tetanus.

Authors:  J C PATEL; B C MEHTA; B H NANAVATI; A K HAZRA; S S RAO; C S SWAMINATHAN
Journal:  Lancet       Date:  1963-04-06       Impact factor: 79.321

4.  [Treatment of manifest tetanus with intra-arterial serum application and pumping of cerebrospinal fluid, tetracyn and autonomic blockade].

Authors:  L CHRISTIAN; G SCHLAG
Journal:  Chirurg       Date:  1956-04       Impact factor: 0.955

5.  [Modern tetanus therapy].

Authors:  R E KLAUSER
Journal:  Munch Med Wochenschr       Date:  1951-01-12

6.  Tetanus.

Authors:  I Ildirim; A R Meira; M L Furcolow
Journal:  N Engl J Med       Date:  1969-05-29       Impact factor: 91.245

7.  A new treatment for neonatal tetanus. Antitetanic serum and prednisolone given together intrathecally.

Authors:  I Ildirim
Journal:  Turk J Pediatr       Date:  1967-07       Impact factor: 0.552

8.  [On the disappearance rate of homologous, parenterally administered, tetanus antibodies in sever tetanus].

Authors:  W Auerswald; H Müller; J Krenn; K Steinbereithner; R Kucher
Journal:  Wien Med Wochenschr       Date:  1968-03-02

9.  Transfer rates of gamma globulin between cerebrospinal fluid and blood plasma (results obtained on a series of multiple sclerosis patients).

Authors:  S W Lippincott; S Korman; L C Lax; C Corcoran
Journal:  J Nucl Med       Date:  1965-09       Impact factor: 10.057

10.  [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].

Authors:  W Auerswald; P Brücke; R Kucher; F Marsoner; H Müller; H Seidl; K Steinbereithner; E Wagner
Journal:  Wien Med Wochenschr       Date:  1966-03-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.